挪威Axis-Shield 
挪威Axis-shield公司一直致力于分离技术的发展，该公司提供的一系列经碘化处理的密度梯度分离液不仅可以分离不同的细胞和细胞器而且可以分离纯化膜囊泡、病毒、蛋白质、核酸以及脂蛋白等物质。特别值得推荐的是，Axis-shield公司最新研制出的OptiprepTM和NycoprepTM Universal是一种全能型的梯度分离液


       

Axis-Shield is a global in vitro diagnostics business with development and manufacturing capabilities and three separate business areas. The company has a Laboratory Division selling to clinical laboratories, a Point-of-Care Division which supplies the near patient test sector, and the distribution businesses of Medinor for the Nordic area and Axis-Shield UK for the United Kingdom. We sell directly, through our own and third party distributors, and also via OEM contracts.

Our vision is "to improve healthcare as a global provider of innovative in-vitro diagnostic products", which is backed up by the following Mission Statement:

"To identify and develop novel, patentable in vitro diagnostic products to meet clinical needs in the laboratory and at the point of care. We will collaborate with partners, create branded products, and add complementary businesses which support our objective of growing an innovative and increasingly profitable company"

We believe our products are making a difference and that we are improving lives by offering innovative, high quality, reliable in vitro diagnostic products which promote improved patient management. Customers may use our products with confidence as we operate to the highest quality standards, with well trained support staff to provide professional advice and help if needed.

Axis-Shield has proprietary technology in near patient testing and a number of patented markers in areas of clinical need. Areas of special focus include cardiovascular and neurodegenerative diseases, rheumatoid arthritis and diabetes. In our home markets of the UK and the Nordic countries we sell not only our own products but also complementary in vitro and other medical devices.

We firmly believe that our products provide clinicians and other healthcare professionals with tools to deliver better patient care. Early, rapid and differential diagnosis of disease in the presence of the patient facilitates the best treatment options and is being increasingly recognised as an essential component of more effective primary care.